Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
2,148
datasets available to search
ShareScore release 0.9.0
Dataset results
2,148 results for “HER2”
Zolbetuximab Claudin18.2 Positive, HER2 Negative, Advanced Gastric Cancer
ClinicalTrials.gov study NCT06767449. IPD Sharing: Not stated. Countries: 1. Publications: 10.
Validity of HER2-amplified Circulating Tumor Cells to Select Metastatic Breast Cancer Considered HER2-negative for Trastuzumab-emtansine (T-DM1) Treatment.
ClinicalTrials.gov study NCT01975142. IPD Sharing: NO. Countries: 1. Publications: 1.
Study of Neratinib +Trastuzumab or Neratinib + Cetuximab in Patients With KRAS/NRAS/BRAF/PIK3CA Wild-Type Metastatic Colorectal Cancer by HER2 Status
ClinicalTrials.gov study NCT03457896. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Study to Compare Pertuzumab + Trastuzumab + Vinorelbine vs. Placebo + Trastuzumab + Docetaxel in Previously Untreated HER2-positive Metastatic Breast Cancer
ClinicalTrials.gov study NCT03811418. IPD Sharing: NO. Countries: 1. Publications: 7.
HER2 Directed Dendritic Cell Vaccine During Neoadjuvant Therapy of HER2+Breast Cancer
ClinicalTrials.gov study NCT03387553. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Phase IIIb Study to Evaluate the Safety and Tolerability of Herceptin SC With Perjeta and Docetaxel in Patients With HER2-positive Advanced Breast Cancer
ClinicalTrials.gov study NCT02402712. IPD Sharing: Not stated. Countries: 12. Publications: 1.
Nivolumab and Eribulin in HER2 Negative Metastatic Breast Cancer
ClinicalTrials.gov study NCT04061863. IPD Sharing: NO. Countries: 1. Publications: 2.
Neoadjuvant Nab-PTX and Trastuzumab for ER Negative and HER2 Positive Breast Cancer
ClinicalTrials.gov study NCT02598310. IPD Sharing: Not stated. Countries: 1. Publications: 1.
PI3K Pathway Activation Markers in ER-Positive, HER2-Negative Breast Cancer: A Clinicopathologic Study
ClinicalTrials.gov study NCT07387861. IPD Sharing: UNDECIDED. Countries: 0. Publications: 14.
Capecitabine + Bendamustine in Women With Pretreated Locally Advanced or Metastatic Her2-negative Breast Cancer
ClinicalTrials.gov study NCT01891227. IPD Sharing: Not stated. Countries: 1. Publications: 1.
T-DM1 and Tucatinib Compared With T-DM1 Alone in Preventing Relapses in People With High Risk HER2-Positive Breast Cancer, the CompassHER2 RD Trial
ClinicalTrials.gov study NCT04457596. IPD Sharing: YES. Countries: 3. Publications: 1.
Clinical Application of ctDNA Dynamic Monitoring in Neoadjuvant Therapy for HER2-positive Breast Cancer Patients
ClinicalTrials.gov study NCT06479460. IPD Sharing: Not stated. Countries: 1. Publications: 5.
Safety and Efficacy of INCB007839 With Trastuzumab and Vinorelbine in Patients With Metastatic HER2+ Breast Cancer
ClinicalTrials.gov study NCT01254136. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Neo-Adjuvant Chemotherapy (TAC) With or Without Zoledronic Acid in Treating HER2-negative Breast Cancer Patients
ClinicalTrials.gov study NCT01099436. IPD Sharing: Not stated. Countries: 1. Publications: 3.
Addition of Carboplatin to Neoadjuvant Therapy for Triple-negative and HER2-positive Early Breast Cancer
ClinicalTrials.gov study NCT01426880. IPD Sharing: Not stated. Countries: 1. Publications: 4.
A Study of MK-2206 in Combination With Trastuzumab and Lapatinib for the Treatment of HER2+ Solid Tumors (MK-2206-015)
ClinicalTrials.gov study NCT00963547. IPD Sharing: YES. Countries: 0. Publications: 1.
Metronomic Capecitabine Plus Aromatase Inhibitor for First Line Treatment in HR(+), Her2(-) Metastatic Breast Cancer
ClinicalTrials.gov study NCT02767661. IPD Sharing: UNDECIDED. Countries: 1. Publications: 1.
Trastuzumab to Patients With Advanced Gastric Cancer With HER2 Positive Expression in CTC
ClinicalTrials.gov study NCT04168931. IPD Sharing: NO. Countries: 1. Publications: 26.
A Study of RC48-ADC in Subjects With HER2-negative Locally Advanced or Metastatic Urothelial Cancer
ClinicalTrials.gov study NCT04073602. IPD Sharing: NO. Countries: 1. Publications: 1.
HER2 Imaging Study to Identify HER2 Positive Metastatic Breast Cancer Patient Unlikely to Benefit From T-DM1
ClinicalTrials.gov study NCT01565200. IPD Sharing: NO. Countries: 2. Publications: 1.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.